Ironwood Pharmaceuticals, Inc. (IRWD) Deep Dive Video

Summary

Ironwood is a highly profitable LINZESS cash-flow story racing to build an apraglutide rare-disease bridge before the 2029 generic cliff.

View IRWD stock page · Read the IRWD research report

Loading the video player…